Le Lézard
Classified in: Transportation, Business, Covid-19 virus
Subjects: PDT, TDS

The Third CIIE is ready to kick off


SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- The third China International Import Expo (CIIE) is entering the final stage of preparations as a huge road paving machine by German company Wirtgen Group became the first exhibit to arrive at the National Exhibition and Convention Center (Shanghai), the host venue of the 3rd CIIE, on Oct 23.

 

CIIE logo

 

In the coming days, more exhibits will enter the venue, and the construction of exhibition booths will be finished by Nov 2.

In light of epidemic control measures, Shanghai customs have offered special services to this year's CIIE exhibitors by setting up 43 special passages and 79 special counters at major ports in the city.

The registration center of the CIIE opened on Oct 23, providing participants with services such as emergency registration and exhibition pass replacement and pickup.

About 500,000 people have registered for this year's expo, and more than 400,000 expo passes have already been dispatched to the applicants by post, according to the CIIE Bureau.

This year, the bureau has issued long-term expo passes, which are valid from 2020 to 2022.

CIIE exhibitors stand to receive a certain amount of tax exemption, including customs duties, value-added tax (VAT) and consumption tax, according to the policy jointly released by the Ministry of Finance, the General Administration of Customs, and the State Taxation Administration on Oct 12.

Each kind of exhibit is subject to a different tax cut. For example, exhibitors of mechanical and electrical equipment can enjoy tax cuts for a maximum of 12 items, while exhibitors of medical equipment can have a maximum of five.

Duties will be levied on exhibitors selling products that exceed the quantity or quota stipulated in the policy, as well as unsold exhibits that are not returned overseas after the expo.

According to epidemic prevention and control measures issued by the Shanghai municipal government on Oct 12, all participants in the CIIE must test negative for COVID-19 before entering the exhibition hall.

All overseas participants are also required to undergo a 14-day health monitoring regime before entering China, and they need to declare their health conditions, have their body temperature checked, and undergo COVID-19 testing upon arrival. A 14-day health quarantine will then be carried out in designated hotels in Shanghai, during which they will have two COVID-19 tests.

Contact?Ms. Nie Qingxin

Tel.?0086-21-67008870/67008988

Logo - https://mma.prnewswire.com/media/1077995/CIIE_Logo.jpg  

 

 


These press releases may also interest you

at 18:00
Quanta X Technology, the parent company of QuantaDose, CEO Katie Webb suggests, "Anyone in Santa's shoes gifting a UVC device to a friend or family member needs to make sure the UV-C device is real, and they also need to understand the potential...

at 17:00
63% response rate in patients treated with the highest reported dose Among all patients responding to treatment, 95% experienced a very good partial response or better; among responding patients with ?6 months of follow-up, 83% have ongoing responses...

at 15:05
ImmunoGen Inc. , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that new safety and efficacy findings from the expansion phase of the Phase 1/2 study of IMGN632 in patients with...

at 15:00
Amgen today announced the first presentation of clinical safety and efficacy data from the Phase 1 study of AMG 701 in heavily pre-treated patients with relapsed/refractory multiple myeloma (R/R MM). AMG 701 is an investigational half-life extended...

at 14:09
The Correctional Service of Canada (CSC) has over 4500 volunteers who dedicate their time and energy to work with and support the offenders in our care and custody. As we mark International Volunteer Day, CSC would like to take this opportunity to...

at 12:46
Three studies being presented during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers....



News published on 29 october 2020 at 15:22 and distributed by: